AKT1 and neoplasm: Activation of the PI3K/AKT/mTOR signaling cascade in tumor cells leads to a feedback increase in sodium–glucose co-transporter (SGLT) 1 and activates glycolysis, thereby promoting Tamoxifen resistance and accelerating tumor growth both in vitro and in vivo [138].